Pneumococcal conjugate second or third-dose vaccines (PCVc) in Germany
Germany: Pneumococcal conjugate second or third-dose vaccines (PCVc) was 74.0% in 2025. ▼ Falling
Latest (2025)
74.0%
Change on year
down 1.3%
World rank
131st
of 194 countries
All-time high
86.0%
in 2011
All-time low
68.0%
in 2008
Years of data
18
2008–2025
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Germany, 2008–2025
Source: World Health Organization, Global Health Observatory.
Analysis
In 2025, pneumococcal conjugate second or third-dose vaccines (pcvc) in Germany stood at 74.0%.
Compared with earlier readings it is down 1.3% on the previous year and down 10.8% over ten years.
Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) in Germany peaked at 86.0% in 2011 and was at its lowest, 68.0%, in 2008.
Germany ranks 131st of 194 countries on this measure, in the middle of the range.
The long-run direction has been consistently falling across the 18 years of available data.
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Germany, year by year
| Year | Value | Change |
|---|---|---|
| 2008 | 68.0% | — |
| 2009 | 84.0% | +23.5% |
| 2010 | 85.0% | +1.2% |
| 2011 | 86.0% | +1.2% |
| 2012 | 84.0% | -2.3% |
| 2013 | 84.0% | +0.0% |
| 2014 | 82.0% | -2.4% |
| 2015 | 83.0% | +1.2% |
| 2016 | 82.0% | -1.2% |
| 2017 | 82.0% | +0.0% |
| 2018 | 82.0% | +0.0% |
| 2019 | 82.0% | +0.0% |
| 2020 | 82.0% | +0.0% |
| 2021 | 82.0% | +0.0% |
| 2022 | 72.0% | -12.2% |
| 2023 | 74.0% | +2.8% |
| 2024 | 75.0% | +1.4% |
| 2025 | 74.0% | -1.3% |
Germany compared with similar countries
- Germany's 74.0% is below the median for high income countries, which is 91.0%, 81% of the median. (63 countries reporting)
- Germany's 74.0% is below the median for Europe & Central Asia, which is 87.0%, 85% of the median. (51 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 76.0% | 68.0% | 84.0% | 2 |
| 2010s | 83.2% | 82.0% | 86.0% | 10 |
| 2020s | 76.5% | 72.0% | 82.0% | 6 |
Countries ranked near Germany
More health data for Germany
- Un projection of annual infant deaths, annual growth rate -2.13 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.9955 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,164 deaths per 1,000 people (2090)
- Number of infants who die before age 1 368 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2000)
- Population ages 00-04, female, annual growth rate -2.18 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0216 units per person (2025)
- Population ages 00-04, male, annual growth rate -2.2 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is pneumococcal conjugate second or third-dose vaccines (pcvc) in Germany?
- Pneumococcal conjugate second or third-dose vaccines (pcvc) in Germany was 74.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Germany?
- The highest recorded value was 86.0% in 2011.
- What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Germany?
- The lowest recorded value was 68.0% in 2008.
- How does Germany rank for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Germany ranks 131st out of 194 countries with data for 2025.
- Is pneumococcal conjugate second or third-dose vaccines (pcvc) rising or falling in Germany?
- Over the last ten years it is down 10.8%. The long-run trend across the full record is falling.
- Where does this Germany data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).